Annual Total Liabilities
$10.81 M
+$425.10 K+4.09%
December 31, 2023
Summary
- As of February 7, 2025, HEPA annual total liabilities is $10.81 million, with the most recent change of +$425.10 thousand (+4.09%) on December 31, 2023.
- During the last 3 years, HEPA annual total liabilities has risen by +$2.69 million (+33.09%).
- HEPA annual total liabilities is now -8.27% below its all-time high of $11.79 million, reached on June 30, 2016.
Performance
HEPA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$4.12 M
+$1.67 M+68.35%
September 30, 2024
Summary
- As of February 7, 2025, HEPA quarterly total liabilities is $4.12 million, with the most recent change of +$1.67 million (+68.35%) on September 30, 2024.
- Over the past year, HEPA quarterly total liabilities has dropped by -$4.72 million (-53.40%).
- HEPA quarterly total liabilities is now -74.63% below its all-time high of $16.25 million, reached on June 30, 2022.
Performance
HEPA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
HEPA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.1% | -53.4% |
| 3 y3 years | +33.1% | -61.0% |
| 5 y5 years | +74.0% | -61.0% |
HEPA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4.1% | -74.6% | +68.3% |
| 5 y | 5-year | at high | +116.5% | -74.6% | +68.3% |
| alltime | all time | -8.3% | +4659.5% | -74.6% | +1041.8% |
Hepion Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.12 M(+68.4%) |
| Jun 2024 | - | $2.45 M(-71.1%) |
| Mar 2024 | - | $8.47 M(-21.7%) |
| Dec 2023 | $10.81 M(+4.1%) | $10.81 M(+22.3%) |
| Sep 2023 | - | $8.84 M(-12.7%) |
| Jun 2023 | - | $10.13 M(-17.9%) |
| Mar 2023 | - | $12.34 M(+18.8%) |
| Dec 2022 | $10.39 M(-1.6%) | $10.39 M(-0.5%) |
| Sep 2022 | - | $10.44 M(-35.7%) |
| Jun 2022 | - | $16.25 M(+76.2%) |
| Mar 2022 | - | $9.22 M(-12.7%) |
| Dec 2021 | $10.56 M(+29.9%) | $10.56 M(+17.8%) |
| Sep 2021 | - | $8.96 M(-0.8%) |
| Jun 2021 | - | $9.03 M(+46.1%) |
| Mar 2021 | - | $6.18 M(-23.9%) |
| Dec 2020 | $8.12 M(+62.7%) | $8.12 M(+8.5%) |
| Sep 2020 | - | $7.49 M(+29.3%) |
| Jun 2020 | - | $5.79 M(+28.6%) |
| Mar 2020 | - | $4.50 M(-9.9%) |
| Dec 2019 | $4.99 M(-19.6%) | $4.99 M(+3.1%) |
| Sep 2019 | - | $4.85 M(-8.7%) |
| Jun 2019 | - | $5.31 M(-26.8%) |
| Mar 2019 | - | $7.26 M(+16.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $6.21 M(-17.7%) | $6.21 M(-36.1%) |
| Sep 2018 | - | $9.73 M(+11.5%) |
| Jun 2018 | - | $8.73 M(+37.5%) |
| Mar 2018 | - | $6.34 M(-30.5%) |
| Dec 2017 | $7.55 M(-19.1%) | - |
| Sep 2017 | - | $9.13 M(-2.1%) |
| Jun 2017 | $9.33 M(-20.9%) | $9.33 M(-23.2%) |
| Mar 2017 | - | $12.15 M(+19.2%) |
| Dec 2016 | - | $10.19 M(-13.7%) |
| Sep 2016 | - | $11.81 M(+0.2%) |
| Jun 2016 | $11.79 M(+508.3%) | $11.79 M(+116.1%) |
| Mar 2016 | - | $5.45 M(-3.7%) |
| Dec 2015 | - | $5.66 M(+34.3%) |
| Sep 2015 | - | $4.21 M(+117.5%) |
| Jun 2015 | $1.94 M(-60.7%) | $1.94 M(+20.0%) |
| Mar 2015 | - | $1.62 M(+347.6%) |
| Dec 2014 | - | $361.00 K(-22.3%) |
| Sep 2014 | - | $464.70 K(-90.6%) |
| Jun 2014 | $4.93 M(+2071.7%) | $4.93 M(-50.6%) |
| Mar 2014 | - | $9.99 M(+1902.4%) |
| Dec 2013 | - | $498.70 K(+25.1%) |
| Sep 2013 | - | $398.60 K |
| Jun 2013 | $227.20 K | - |
FAQ
- What is Hepion Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual total liabilities year-on-year change?
- What is Hepion Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly total liabilities year-on-year change?
What is Hepion Pharmaceuticals annual total liabilities?
The current annual total liabilities of HEPA is $10.81 M
What is the all time high annual total liabilities for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual total liabilities is $11.79 M
What is Hepion Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, HEPA annual total liabilities has changed by +$425.10 K (+4.09%)
What is Hepion Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of HEPA is $4.12 M
What is the all time high quarterly total liabilities for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly total liabilities is $16.25 M
What is Hepion Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, HEPA quarterly total liabilities has changed by -$4.72 M (-53.40%)